2024-11-19 17:46:05
Brii Biosciences Presents Promising Clinical Data to Support Ongoing Development of Novel HIV Therapeutic Candidates at IDWeek 2022
Corporate/ 2023-07-24
Brii Biosciences Presents Promising Clin...

Findings from two Phase 1 studies show both BRII-732 and BRII-778 are safe and well-tolerated Results indicate potential for oral once-weekl...

Innovent Announces Phase Ib Results of Higher-dose Mazdutide (IBI362) in Chinese Participants with Overweight or Obesity Published in eClinicalMedicine
Corporate/ 2023-07-24
Innovent Announces Phase Ib Results of H...

ROCKVILLE,Md. and SUZHOU,China,Oct. 17,2022-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical c...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release